Big Gain For Standard BioTools Inc Com
Mon, May 23, 2022 at 05:30 PM
Standard BioTools Inc Com (LAB:NASDAQ) soared at $2.6, a gain of 33.3%. On Fri, May 20, 2022, LAB:NASDAQ hit a New 2-Week Low of $1.95. The stock appeared on our News Catalysts scanner on Thu, May 05, 2022 at 06:25 PM in the 'EARNINGS' category. From Mon, May 09, 2022, the stock recorded 33.33% Up Days and 20.00% Green Days
About Standard BioTools Inc Com (LAB:NASDAQ)
Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies.
Top 10 Gainers:
- Catalyst Biosciences, Inc. (CBIO:NASDAQ), 234.21%
- Lixiang Education Holding Co. Ltd. (LXEH:NASDAQ), 58%
- View Inc. (VIEW:NASDAQ), 43.35%
- Predictive Oncology Inc. (POAI:NASDAQ), 40.74%
- Standard BioTools Inc Com (LAB:NASDAQ), 33.33%
- Sanchez Midstream Partners LP (SNMP:NYSEMKT), 32.81%
- Evolving Systems, Inc. (EVOL:NASDAQ), 32.14%
- Neonode Inc. (NEON:NASDAQ), 28.8%
- O2Micro International Limited (OIIM:NASDAQ), 28.57%
- Sonder Holdings Inc. (SOND:NASDAQ), 27.43%